Biosimulation Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Biosimulation Market 

5.1. COVID-19 Landscape: Biosimulation Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Biosimulation Market, By Product

8.1. Biosimulation Market, by Product Type, 2023-2032

8.1.1. Software

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Services

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Biosimulation Market, By Application

9.1. Biosimulation Market, by Application, 2023-2032

9.1.1. Drug Discovery

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Drug Development

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Others

9.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Biosimulation Market, By End User Type 

10.1. Biosimulation Market, by End User Type, 2023-2032

10.1.1. Regulatory Authorities

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Pharmaceutical & Biotechnology Companies

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Contract Research Organizations (CROs)

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Academic Research Institutes

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Biosimulation Market, By Delivery Model Type 

11.1. Biosimulation Market, by Delivery Model Type, 2023-2032

11.1.1. Subscription Models

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Ownership Models

11.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Biosimulation Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.1.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.5.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.1.5.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.6.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.1.6.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.2.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.5.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.2.5.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.6.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.2.6.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.7.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.2.7.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.8.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.2.8.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.3.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.5.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.3.5.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.6.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.3.6.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.7.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.3.7.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.8.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.3.8.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.4.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.5.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.4.5.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.6.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.4.6.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.7.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.4.7.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.8.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.4.8.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.5.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.5.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.5.5.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.6.3. Market Revenue and Forecast, by End User Type (2020-2032)

12.5.6.4. Market Revenue and Forecast, by Delivery Model Type (2020-2032)

Chapter 13. Company Profiles

13.1. Biovia

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Certara

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Compugen Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Genedata

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. In Silico Biosciences, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Leadscope Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Pharmaceutical Product Development, LLC.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Schrödinger, LLC.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Simulations Plus, Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. DassaultSystemes

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms